chemotherapy-free regimen

Cecilia BrownPrint | February 1, 2023

The number of "chemotherapy-free" drugs and regimens grows as more is learned about the biology of hematologic malignancies.

Leah SherwoodAcute Lymphoblastic Leukemia | November 22, 2022

Advances have been accomplished in the management of adults with acute lymphoblastic leukemia...

Kerri FitzgeraldChronic Lymphocytic Leukemia | February 1, 2023

Three-year follow-up data from the CAPTIVATE trial were presented at the 2022 ASCO Annual Meeting.

Editorial Board

Sagar Lonial, MD, FACPEditor-in-Chief | Chief Medical Officer of Winship Cancer Institute at Emory University School of Medicine

Guillermo Garcia-Manero, MDAssociate Editor | Chief, Section of Myelodysplastic Syndromes, The University of Texas MD Anderson Cancer Center

Elias Jabbour, MDExecutive Editor | DB Lane Cancer Research Fund Distinguished Professor in Leukemia Research, MD Anderson Cancer Center

Kami Maddocks, MDAssociate Editor | Professor of Clinical Internal Medicine in the Division of Hematology at The Ohio State University

Thomas Martin, MDAssociate Editor | Clinical Research Director, UCSF Helen Diller Family Comprehensive Cancer Center

Jerald Radich, MDAssociate Editor | Professor in the Clinical Research Division and Kurt Enslein Endowed Chair at Fred Hutch

Laurie Sehn, MD, MPHAssociate Editor | Clinical Professor of Medical Oncology, British Columbia Cancer Centre for Lymphoid Cancer